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The Relationship Between Uncertainty in Illness and Anxiety in Patients With
Cancer
Naima Vera
ABSTRACT
Anxiety is a common problem for patients with cancer. Anxiety may have a
negative impact on decision making and overall emotional well being of patients
and may be related to the uncertainties faced by people with cancer. This study
examined the relationship between uncertainty in illness and anxiety in patients
with cancer.
The sample consisted of 30 patients, predominantly males (n=23), being
treated as outpatients in the Clinical Research Unit at a National Cancer Institute
designated cancer center in Florida. After agreeing to participate, patients
completed the State-Trait Anxiety Inventory as well as Mishel‟s Uncertainty in
Illness Scale.
Participants‟ ages ranged from 21 to 86, with a mean age of 64 years.
Forty percent of the patients completed high school, 30% had some college
education and almost 30% had a bachelor‟s degree or higher. Almost 47% of the
sample had melanoma, other patients had renal cancer (n=3), or pancreatic
cancer (n=2), acute myeloid leukemia (n=2), sarcoma (n=2), lung cancer (n=2),
iv

myeloma (n=2), chronic myeloid leukemia (n=1), glioblastoma (n=1), and rectal
cancer (n=1). Seventy percent of the patients had stage IV disease.
The results of the study showed a significant positive relationship between
uncertainty and both state anxiety (r=0.52, p=0.00.) and trait anxiety (r=0.61,
p=0.000). A significant positive relationship was also found between the
uncertainty subscale of ambiguity and both, state anxiety (r=0.538, p=0.002) and
trait anxiety (r=0.56, p=0.001). Both state anxiety (r=0.39, p=0.034) and trait
anxiety (r=0.64, p=0.000) were positively related to the uncertainty subset of
inconsistency.
Although the sample size was small and not demographically diverse, the
findings of this study are supportive of previous studies. The implications of this
study in nursing are significant because they examine two emotional aspects that
evidently exist among cancer patients, and that very likely cause distress to this
population. The findings of this study suggest that additional focus in uncertainty
and anxiety should take place in the clinical outpatient setting.
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Chapter One Introduction
Cancer represents the second most common cause of death in the
Western world (American Cancer Society, 2008). Despite the progress in
medicine, cancer is often considered a synonym of death, pain and suffering
(Powe & Finne, 2003). Cancer is not considered a single event but a permanent
condition with ongoing ambiguity, or uncertainty, delayed effects of the disease
and its treatments and concurrent psychological issues (Zebrack, 2000).
A diagnosis of cancer is a life changing and potentially fatal event that can
be associated with feelings of uncertainty (Shaha, Cox, Talman, & Kelly, 2008)
leading to anxiety. Notions of uncertainly concerning the cancer experience have
been associated with anxiety (Decker et al., 2007) in that 48% of lymphoma
patients reported levels of anxiety high enough to be diagnosed with an anxiety
disorder (Stark et al., 2002).
Mishel (1988) defined uncertainty in illness as the inability to determine
the meaning of illness-related events. Uncertainty is a component of all illness
experiences and it is believed to affect psychosocial adaptation and outcomes of
disease (McCormick, 2002). High levels of uncertainty are related to high
emotional distress, anxiety and depression (McCormick, 2002).
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Anxiety can be defined as a state of uneasiness to a potential threat that is
inconsistent with the expected events (Bay & Algase, 1999) and can be
associated with feelings of fear, dread, and uneasiness (National Cancer Society,
2008). The threat of cancer may elicit this state of uneasiness. Higher anxiety
levels have been found in cancer patients who are aware of their diagnosis
compared to a group of patients without awareness (Tavoli, Mohagheghi,
Montazer, Roshan, Rasool, and Omidvari, 2007).
Problem Statement
Defining the relationship between uncertainty and anxiety is important
because it can lead to further studies that focus on the simultaneous
management of uncertainty and anxiety as well as their impact on quality of life
(QOL). Uncertainty remains one of the single greatest source of stress for people
affected by a life-threatening illness such as cancer (Santacroce, 2002). Stark et
al. studied anxiety in 178 patients with lymphoma, renal cell carcinoma,
melanoma and plasma cell dyscrasia. They found that 48% of these patients had
levels of anxiety high enough to qualify for anxiety disorder. According to
Pitcealthy et al. (2009) most cancer patients report distress within the first year of
diagnosis and up to 40% develop anxiety which impairs the quality of life for the
patient.
Uncertainty and anxiety are experienced by most patients with cancer due
to the inability to determine the meaning of illness-related events and to the
potential threat that the cancer diagnosis poses. Although anxiety and
2

uncertainty are important factors and are commonly experienced by cancer
patients, little research was found during the review of literature that focused on
evaluating a relationship between the two. The purpose of this study was to
examine the relationship between uncertainty in illness and anxiety in patients
with cancer.
If a relationship between uncertainty and anxiety is defined, there is a
possibility that decreasing uncertainty may in turn decrease anxiety. Although
things may never be normal after a patient is diagnosed with cancer, oncology
nurse practitioners should have effective and clear communication as a simple
but successful way to reduce uncertainty, and simultaneously decrease anxiety.
A relationship between uncertainty and anxiety may give rise to future research
to reduce uncertainty and anxiety during all stages of cancer.
Research Questions
The following questions guided this study:
1. Is there a significant positive relationship between uncertainty and trait anxiety
in outpatients in a cancer center who have been diagnosed with cancer?
2. Is there a significant positive relationship between uncertainty and state
anxiety in outpatients in a cancer center who have been diagnosed with cancer?
3. Are there significant positive relationships between uncertainty in illness
subscales and either state or trait anxiety?
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Definitions of Terms
Uncertainty in illness. Uncertainty is an inability to determine meaning in
illness situations (Mishel, 1988). Uncertainty in cancer is directly related to not
knowing about cancer. Uncertainty is influenced by factors that change from
person to person. Therefore, the definition of uncertainty in illness is individual
and specific to one person. The term itself is directly related to not knowing. The
concept is taken a step further when referring to uncertainty in cancer.
Uncertainty remains one of the single greatest source of stress for people
affected by a life-threatening illness such as cancer (Santacroce, 2002).
Anxiety. Two types of anxiety have been defined; state anxiety and trait
anxiety. State anxiety is a temporary condition in response to a stressful
situation, like a cancer diagnosis. Trait anxiety is defined as a more general and
long-standing quality (Spielberger, 1983).
Anxiety is a reaction to stress due to the thought of negative
consequences of the illness. Anxiety is a threat to homeostasis, a presence of
impending change, a sense of loss, uneasiness or increased apprehension.
Anxiety has been defined as a heightened state of uneasiness to a potential
threat that is inconsistent with the expected events and results when there is a
mismatch between the next likely event and the actual event (Bay & Algase,
1999).
Anxiety can interfere with personal growth, physical health and behavior.
Clinical expression of anxiety may include increasing tension, worry, fright,
4

trembling, quivering voice, arousal and jitters (Bay & Algase, 1999). Many times
the source of anxiety is unknown; however in cancer, the source of anxiety is
related to the impact of the diagnosis in one‟s life.
Significance to Nursing
This study may contribute to the future enhancement of the clinical
treatment of anxiety in cancer patients in any stage of disease and treatment
modality. In addition, this study may contribute to the limited research in
uncertainty and anxiety of cancer patients. Good clinical guidelines are currently
lacking in the identification and treatment of uncertainty, and early recognition
may help reduce the associated anxiety. Enhanced awareness of the potential
problems associated with the uncertainty frequently experienced by cancer
patients may motivate nurses to develop better management strategies.
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Chapter Two Review of Literature
This chapter presents the background for the study. A review of relevant
research literature in uncertainty and anxiety is presented. This is followed by a
summary and implications for nursing. Finally, gaps in the literature are
presented.
Uncertainty in Illness
Uncertainty in illness has been studied using several different frameworks.
Mishel (1981) has widely studied the concept of uncertainty in cancer using the
Mishel‟s Uncertainty in Illness Scale (MUIS) to measure uncertainty. The scale
presents four major factors which are: ambiguity, unpredictability, complexity and
inconsistencies. Many have studied the concept of uncertainty in cancer and
have based their studies on Mishel‟s Theory of Uncertainty in Illness. Mishel‟s
model suggests coping is initiated to reduce uncertainty, especially when danger
is perceived. In addition, coping is initiated to maintain the belief in a positive
outcome when uncertainty is appraised as an opportunity.
A study conducted by Wallace et al., (2007) explored the three main
domains established by Mishel, which include: uncertainty about disease and
treatment, danger appraisal, and opportunity appraisal. The investigators used
older men with prostate cancer undergoing watchful waiting as their population.
6

The defining features of uncertainty about disease and treatment were found to
be: few signals to monitor progression of disease, lack of physical discomforts
made it hard to believe that the cancer was there, lack of symptoms created
uncertainty as cancer was perceived as related to pain and suffering, physician
unable to tell how fast tumors grow, elevated PSA levels do not always indicate
cancer, stable levels do not always indicate stable disease. Danger appraisals
were found to be: treatment decision making was found as an appraisal of
danger, lack of clear guideline and multiple alternatives, the newness of watchful
waiting made them wonder if it was aggressive enough.
Interestingly, Wallace‟s (2007) study also noted that while uncertainty was
consistently present in all patients after making the decision of watchful waiting,
this offered the opportunity to manage their uncertainty by continuing to work,
self-caring, keeping options open, using alternative medicine and praying,
imagining cancer as small, by envisioning the smallness of their localized tumor,
watch and wait provided an option to aggressive therapy or surgery that many
times lead to poor outcomes and poor quality of life.
Mishel‟s re-conceptualization of Uncertainty in Illness Theory has also
been used to study and explain the relationship between uncertainty and post
traumatic stress syndrome. Lee (2006) conducted a study to examine the
relationship between uncertainty and post traumatic stress syndrome in young
adults, survivors of childhood cancer. It was found that post traumatic stress
syndrome develops and is adopted by the survivors of childhood cancer as a
7

maladaptive strategy to manage uncertainty when they lack of sufficient
resources for coping with the challenges of survivorship. Furthermore, avoidance
and arousal, which are two symptom clusters of post traumatic stress disorder,
were found to be related to uncertainty. Once again the study suggests that
providing health related information appropriately (without ambiguity, low
complexity, and no unpredictably) could potentially help alleviate or decrease
uncertainty in cancer survivors.
Uncertainty throughout the cancer experience. Uncertainty does not
diminish beyond diagnosis; therefore, uncertainty should continue to be
addressed even throughout survivorship (Decker, Haase & Bell, 2007). In their
study, Decker, et.al., (2007) used Michel‟s uncertainty model to study uncertainty
in cancer patients. They found that there are no significant differences in the
overall level of uncertainty among the newly diagnosed, diagnosed 1 to 4 years
and diagnosed more than 5 years. However, newly diagnosed patients scored
high uncertainty for future pain, unpredictable illness course, staff responsibility,
and concerns about caring for themselves. Those diagnosed 1 - 4 years and 5 or
more years, had high uncertainty about the multiple meanings of communication
from the doctors. Those diagnosed 5 years or more had higher uncertainty about
knowing what was wrong, had more unanswered questions and had higher
uncertainty regarding the probability of successful treatment. Their study
emphasizes the importance of certainty to provide open communication beyond
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diagnosis and the cancer treatment phase. In addition, results suggests that the
type of information needed changes during each stage of the cancer experience.
Mishel, along with Gil, Belyea, Germino, Porter, and Clayton (2006)
reported significant benefit in providing cognitive behavioral strategies and self
help manuals to increase recurrence free breast cancer survivor knowledge.
Mishel et al. (2006) conducted a study that found that even after 10 months of no
interventions, these women were able to integrate the changes and skill gained
during intervention even without the direct guidance.
This same patient sample was used to gather data regarding triggers of
uncertainty (memories, feelings, concerns) about cancer recurrence and physical
symptoms from treatment side effects. The study found that hearing about
someone else‟s cancer and pains, was the most frequent trigger of uncertainty.
It was also found that in both Caucasian and African Americans, the most
frequent symptoms linked to long-term treatment side effects were fatigue, joint
stiffness, and pain. In 2006, Lee studied post traumatic stress disorder and
uncertainty. This study found that there is a relationship between post traumatic
stress disorder (PTSD) and uncertainty suggesting that cancer survivors adopt
PTSD as a way to manage uncertainty.
Ethnic differences and uncertainty. Ethnic differences were also evaluated
in research. Caucasian women were found to be more likely than African
American women to report that their fears of recurrence were triggered by
hearing about someone else‟s cancer while for African American the most
9

common trigger was new symptoms. The study also concluded that uncertainty
remains after cancer diagnosis and treatment and that these survivors
experienced triggers of uncertainty on a regular basis, with an average of 2
triggers per month (Gil, et al., 2006).
The study helps to better understand that during cancer survivorship
uncertainty should still be identified, monitored and managed along with
emotional distress. Giving specific information about symptoms that are
commonly experienced as late effects of treatment is important in reducing
anxiety in patients. Education, counseling and support should be offered to help
patients cope with unexpected encounters that trigger uncertainty of recurrence
as these triggers are often found in daily occurrences.
Germino et al., (2007) found that ethnic differences exist in the
relationship of uncertainty to a number of quality of life and coping variables. In a
study of female breast cancer survivors (Gil et al., 2006), the investigators found
that the women were not only benefiting from being able to identify and use
information about their illness, but they were also able to integrate this
information without direct guidance.
Communication. In a study by Clayton, Mishel and Belyea (2006) the
concept of uncertainty and how communication with health care providers may
help women reduce uncertainty and improve both emotional and cognitive wellbeing was investigated. A positive association was found between health care
provider communication and thoughts of recurrence. More than half of the
10

sample indicated that they were unable to achieve their desired decision-making
role with health care providers. An interesting finding that health care providers
might be offering information that contributes to thoughts of recurrence is a
possibility raised by the study.
Anxiety in Cancer
According to Stark et al. (2002) anxiety is a response to a threat and given
that cancer is a threat, many patients with cancer experience anxiety. Stark et al.
(2002) studied anxiety in 178 patients with lymphoma, renal cell carcinoma,
melanoma and plasma cell dyscrasia. They found that 48% of these patients had
levels of anxiety high enough to qualify for anxiety disorder. This study also found
that the most accurate screening questionnaires for anxiety include the StateTrait Anxiety Inventory and the Hospital Anxiety and Depression Scale.
Symptoms of anxiety are common among cancer patients and therefore, it is
appropriate to screen for anxiety and understand the impact of anxiety in cancer
patients‟ quality of life.
Tavoli et al. (2007) found that psychological distress is higher in patients
who are aware of their cancer diagnosis when compared to those patients who
are not aware of their diagnosis. Tavioli et al. conducted a cross-sectional study
to examine anxiety in 142 patients with gastrointestinal cancer patients and
investigated whether the knowledge of cancer diagnosis affects patients‟
psychosocial status. Of these cancer patients, 52% were not aware of their
diagnosis and 48% were aware of having cancer. The mean anxiety score was
11

7.6 (SD=+/-4.5) and 47.2 % of the patients had high anxiety score. A significant
difference was noted between those who knew their diagnosis (anxiety means
score of 9.1) versus those who did not know (anxiety means score of 6.3); P
<0.001. After performing regression analysis it was found that anxiety showed
strong relationships with knowledge of cancer diagnosis.
It is important to be aware of the role that intrusive cognition plays in
anxiety and adaptation of the experience of living with a cancer diagnosis. In a
study conducted by Whitaker et al. (2007) patients with cancer classified as
anxious reported intrusive or disturbing imagery significantly more times than
non-anxious patients (P<0.01). Anxious patients also reported more intrusive
thoughts (P<0.01) and more intrusive memories (P<0.05). No correlation was
found between intrusive cognition and disease stage (P=0.98). The study also
found that intrusive imagery in these cancer patients is a factor in psychological
morbidity.
Patient symptom reporting is important and significant in guiding treatment
and diagnosis of cancer. A study published by Leventhal, Schmitz, Rabin, and
Ward (2001) found that anxiety is positively related with vague symptom
reporting and not related to concrete symptom reporting in patients undergoing
chemotherapy treatment. The study findings suggest that trait anxiety was
positively related with over reporting of symptoms and supports that although
trait-anxious individuals pay closer attention to symptoms as they occur, the
symptom reporting is often vague rather than concrete (Leventhal et al., 2001).
12

Studies have found that psychological interventions at time of diagnosis
may promote adjustment in newly diagnosed cancer patients. Pitceathly et al.
(2008) studied 313 patients newly diagnosed with cancer. These patients were
free of anxiety or depressive disorders at the time of diagnosis. The patients
were separated in high risk of developing anxiety and low risk. Patients were
then randomized to receive immediate psychological interventions, delayed
psychological intervention or no psychological intervention. The study reports
that twelve months after intervention, patients at high risk who received
intervention were less likely to develop an anxiety disorder. In the low risk group
no differences were noted.
Gattellari, Butow, and Tattersall (2001) studied 233 patients with cancer
who were visiting their oncologist for first time. They found that anxiety levels
significantly decreases pre consultation and post consultation when patients
preferred and perceived roles matched. Nevertheless, they found that most
cancer patients fail to achieve their desired level of involvement in their care.
Their result also supported that less involvement than patient preferred, appears
to be more detrimental to anxiety levels than more involvement than preferred.
Summary of Literature Reviewed
In regard to uncertainty, the review of literature suggests that the concept
of uncertainty is a dynamic one that is mostly determined by the present situation
and its factors (Mishel, 1981). In regard to anxiety, the literature proposes that
patients diagnosed with cancer and aware of their disease have higher levels of
13

anxiety (Tavoli et al., 2008). The relationship between uncertainty and anxiety
was not directly addressed in the literature reviewed.
Literature reviewed related to anxiety and psychological distress in cancer
patients is higher in cancer patients aware of their diagnosis (Tavoli et al., 2008).
The study encourages early implementation of methods to reduce anxiety after
giving a cancer diagnosis and constant assessment of anxiety is crucial in the
care of cancer patients. Whitaker et al., (2007) concluded that intrusive
cognitions were associated with person‟s own experience of having cancer and
that intrusive cognition was most strongly associated with anxiety. The study
makes providers aware of the role that intrusive cognition plays in anxiety and
adaptation of the experience of living with a cancer diagnosis.
In uncertainty, the literature findings focused on assessment and
management of uncertainty in cancer patients. Decker and colleges (2007)
clearly suggest that uncertainty is related to quality of life and psychological
health outcomes. Furthermore, their study found that uncertainty is present in all
stages of illness and can be reduced using effective communication and taking
into consideration ethnic and cultural differences. Decker and colleagues
demonstrated that the degree of uncertainty changes during each stage of the
cancer experience and that it continues throughout survivorship. Interestingly,
Clayton et al., (2006) found that there is a possibility that healthcare providers
contribute to thoughts of recurrence, increasing patients‟ feelings of uncertainty.
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To identify a relationship between uncertainty and anxiety would be
valuable to nursing and to cancer patients. If a positive relationship is found
between the two, it would be possible to do further research in the simultaneous
assessment and management of both co-morbidities and the impact that one has
on the other. The literature reviewed emphasized the importance of uncertainty
and anxiety in health outcomes and quality of life, justifying further research in
this area.
Implications for Nursing
The field of oncology has much to gain from further studies in uncertainty
and anxiety in patients diagnosed with cancer. Ways to manage uncertainty have
been thoroughly studied in many areas and stages of cancer. The studies
reviewed consistently demonstrate that healthcare providers can contribute to
decreasing uncertainty in our patients. For example, the data analyzed by Gil et
al. (2006) demonstrated that a group of female breast cancer survivors were able
to integrate the changes and skills gained during guided uncertainty intervention
even without the direct guidance. If a positive relationship between uncertainty
and anxiety is defined, further research can be done in the management of
anxiety in oncology. In nursing, understanding the concept of uncertainty and
anxiety and its possible relationship is important because proper management of
these can allow patients to participate in their decision making process
throughout their illness as well as it can eliminate a huge barrier to patients‟
participation in their care.
15

Gaps in the Literature
There is a noticeable gap in the literature regarding assessment and
management of anxiety specifically in patients with cancer. Much is said about
anxiety in general, but little is related specifically to the oncology population and
healthcare providers. The current literature does have plenty of information about
uncertainty in illness, and specifically in cancer. The literature has studies about
uncertainty in the different stages of a cancer experience; at diagnosis, during
treatment and in survivorship. Studies on managing uncertainty are lacking.
Finding a relationship between uncertainty and anxiety may be able to fill
some gaps, specifically regarding anxiety and cancer. The relationship may also
encourage further research in the simultaneous assessment and management of
both, uncertainty and anxiety.

16

Chapter Three Methods
A descriptive cross-sectional design was used to identify the relationship
between uncertainty and anxiety in patients with cancer. A literature review on
uncertainty and anxiety in patients with cancer sustains the belief that a positive
relationship between uncertainty and anxiety might exist. The study design, tools
used, procedure and statistical analysis are discussed in this chapter.
Setting and Sample
The sample for this study was gathered from patients in the Clinical
Research Unit (CRU) outpatient setting of a National Cancer Institute designated
center in southwest Florida. Thirty patients were accrued to the study.
Patients enrolled in the study met the following inclusion criteria: over
eighteen years old, able to read, write and understand English, pathologically
diagnosed with cancer for at least 4 weeks prior to study enrollment as located
on pathology report in patients‟ medical record, aware of cancer diagnosis for at
least 4 weeks prior to study enrollment as documented by physician in patients‟
medical record.
The following criteria excluded patients: being an inpatient at the time of
encounter, being unaware of their cancer diagnosis, having untreated and/or
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symptomatic brain metastasis or psychiatric diagnosis. Information about
psychiatric diagnosis was abstracted from the medical record.
Instruments
Mishel’s Uncertainty in Illness Scale (MUIS). The Uncertainty in Illness
Scale (Mishel, 1983) was used to measure uncertainty (Appendix A). The MUIS
is a 33-item self-administered tool designed to measure acuity of uncertainty in
illness. This instrument has four subscales: ambiguity or cues about the state of
illness being vague and indistinct, tending to overlap (13 items, coefficient of .91),
complexity or cues about treatment and system of care are multiple, intricate and
varied (7 items, coefficient alpha of .75), inconsistency or information that
changes frequently or is not in accord with information previously received (5
items, coefficient alpha of .71), and unpredictability (6 items, coefficient alpha of
.70). Scores for ambiguity can range from 13 to 65. Scores for inconsistency can
range from 7 to 35. Scores for complexity can range from 7 to 25. Scores for
unpredictability can range from 5 to 25.
To complete the questionnaire, subjects selected the degree to which they
agreed or disagreed with thirty-three statements related to uncertainty. Items are
scored on a five point Likert-type scale that ranges from „strongly agree‟ to
„strongly disagree‟. The highest possible total score is one hundred and sixty with
higher scores indicating greater levels of uncertainty.
State Trait Anxiety Inventory (STAI). The State Trait Anxiety Inventory
(STAI) was used to measure anxiety (Appendix A & B). It is a self administered
18

tool that differentiates between temporary condition of anxiety (state) and a long
standing anxious quality (trait). The STAI has a total of 40 questions; 20 testing
state and 20 testing trait. Each question has four possible answers. Items are
scored on a 4-point Likert-type scale, with response going from 1 (not at all) to 4
(very much so). The highest score is 160; the lowest is 40. High scores indicate
higher levels of anxiety. The alpha coefficients for the state anxiety scale ranges
from 0.83 to 0.94. The trait anxiety scale has a median alpha coefficient of 0.90
(Spielberger, 1983).
Procedures
The study was approved by the Scientific Review Committee of the cancer
center and the University of South Florida Institutional Review Board. The
investigator identified the patients via the medical record for inclusion criteria.
Once identified, patients were invited to participate and the study was explained.
Patients who agreed to participate signed an informed consent form (Appendix
F). The demographic data was retrieved via the medical record and recorded on
a hard copy data form. The participants complete two study questionnaires
during the research encounter with the primary investigator. The research
encounter required approximately 30 minutes after consent process. Patients
were instructed that the interviews could be stopped at any time. The interviews
were held in a private area in the clinical research unit. Personal identifiers were
removed from all study related paperwork except for the informed consent form.
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Original copies of the signed ICF and all study related paperwork are kept in the
study binder and securely locked.
Data Analysis
The research questions that guided this study were: Is there a significant
positive relationship between uncertainty and trait anxiety in outpatients in a
cancer center who have been diagnosed with cancer?, Is there a significant
positive relationship between uncertainty and state anxiety in outpatients in a
cancer center who have been diagnosed with cancer?, Are there significant
positive relationships between uncertainty in illness subscales and either state or
trait anxiety.
Descriptive statistics, including means, standard deviations, frequencies
and percentages, were used to describe the patient sample. To address the
questions, Pearson correlation were used to determine the relationship of
uncertainty and state and trait anxiety, as well as the relationship between
uncertainty subscales and state and trait anxiety.
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Chapter Four Results, Discussion and Conclusions
This chapter presents the findings of the study to include: results,
discussion of the results, implications for nursing, conclusion and suggestions for
future research.
Results
Demographic data. The sample consisted of 30 patients with ages ranging
from 21 to 86 years, with a mean age of 64. Twenty three males participated in
the study while only 7 females agreed to participate (Table 1).
Table 1
Frequency and Percent of Participants by Gender
Gender

Frequency

Percentage

Female

7

23.3

Male

23

76.7

Educational background of the sample was varied. Three percent of the
sample did not complete high school, 40% had a high school diploma, 30%
completed some college, almost 17% had a bachelor‟s degree, 2 patients had a
doctoral degree and 1 had a master‟s degree (Table 2).
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Table 2
Frequency and Percent of Participants by Level of Education
Level of Education

Frequency

Percentage

Some High School

1

3.3

High School Diploma

12

40.0

Some College

9

30.0

Bachelor‟s

5

16.37

Master‟s

1

3.3

Doctorate

2

6.7

Almost 47% of the sample had melanoma, other patients had renal (n=3),
pancreatic (n=2), acute myelogenous leukemia (n=2), sarcoma (n=2), lung
cancer (n=2), myeloma (n=2), chronic myelogenous leukemia (n=1), glioblastoma
(n=1), and rectal cancer (n=1). Seventy percent of the patients had stage IV
disease. (Table 3).
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Table 3
Frequency and Percent of Participant’s Diagnosis and Stage
Diagnosis

Frequency

Percent

Melanoma

14

46.7

Renal

3

10.0

Pancreatic

2

6.7

Acute myelogenous

2

6.7

Sarcoma

2

6.7

Lung

2

6.7

Myeloma

2

6.7

Chronic myelogenous

1

3.3

Glioblastoma

1

3.3

Rectal

1

3.3

I

2

0.1

III

4

0.1

IV

21

0.7

3

0.1

leukemia

leukemia

Stage

UNKNOWN
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Time since diagnosis ranged from less than 6 months to over 5 years
(Table 4). Twenty percent of the patient had been diagnosed between 1-2 years
from time of enrollment. Thirteen percent had been diagnosed within 6 months,
and almost 17 % of the sample was diagnosed within 3 to 4 years. Seventeen
percent of the sample was diagnosed within the last 6 months to a year.
Seventeen percent of the sample was diagnosed more than five years from the
time of enrollment, and only 10% of the patients were diagnosed for 2 to 3 years.
Table 4
Frequency and Percent of Participants’ Time Since Diagnosis and State Anxiety,
Trait Anxiety and MUIS Mean Scores and Standard Deviations by Time of
Diagnosis.
Time since diagnosis

Frequency
(%)

State Anxiety
Mean
(Standard
Deviation)

Trait Anxiety
Mean
(Standard
Deviation)

MUIS
Mean
(Standard
Deviation)

< 6 months

4 (13.3)

33.8 (12.1)

29.8 (7.4)

90.5 (13.2)

6 months to 1year

5 (16.7)

33.0 (9.9)

30.6 (8.3)

84.0 (8.9)

1 to 2 years

6 (2.0)

29.8 (10.0)

28.3 (10.6)

83.8 (11.4)

2 to 3 years

3 (10.0)

35.0 (7.0)

33.3 (2.5)

80.3 (6.1)

3 to 4 years

5 (16.7)

36.8 (11.3)

35.8 (9.7)

94.4 (7.6)

4 to 5 years

2 (6.7)

21.0 (1.4)

24.0 (.0)

81.5 (9.2)

5 years or more

5 (16.7)

28.6 (8.6)

33.6 (10.5)

86.0 (9.5)

Total

30 (100.0)

31.8 (9.7)

31.2 (8.6)

86.4 (11.4)
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State-Trait Anxiety. The State-Trait Anxiety Inventory was used to
measure state and trait anxiety. The mean score of the state anxiety inventory
was 31.8 with a standard deviation of 9.7. The mean score of the trait anxiety
inventory was 31.2 with a standard deviation of 8.6 (Table 4). No relationship
was found between anxiety and age, gender, diagnosis, stage, educational level
and time since diagnosis. Nevertheless, there was a trend towards higher mean
scores in state anxiety, and trait anxiety in patients diagnosed within three to
fours years (Table 4).
Table 5
Correlations of Uncertainty with State and Trait Anxiety
R

P

State Anxiety

0.52

0.003

Trait Anxiety

0.61

0.000

Uncertainty in illness. Mishel‟s Uncertainty in Illness Scale was used to
measure uncertainty. No significant correlation was found between uncertainty
and age, gender, diagnosis, stage, educational level and time of diagnosis.
Interestingly, patients diagnosed within three to four years had slightly higher
mean scores on the MUIS (Table 4).
The subscales ambiguity, complexity, inconsistency and unpredictability
were also measured. The mean score for ambiguity was 31.1 with a standard
deviation of 11.4. The mean score for complexity was 27.2, with a standard
deviation of 4.2. The mean score for inconsistency was 13.8, with a standard
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deviation of 4.8. Finally, the mean score for predictability was 12.3 with a
standard deviation of 2.6.
Relationship between uncertainty and anxiety. A significant positive
relationship was found between ambiguity and state (r=0.53, p=0.002) and trait
anxiety (r=0.56, p=0.001) (Table 6, 7). A significant positive relationship was also
found between inconsistency and state (r=0.389, p=0.034) and trait anxiety
(r=0.64, p=0.000) (Table 6, 7). No relationship was found between state- trait
anxiety and complexity and unpredictability (Table 6, 7). Trait anxiety was
significantly higher in people with higher levels of uncertainty (r=0.61, p=0.000)
(Table 5). State anxiety was also positively related with higher levels of anxiety
(r=0.52, p=0.003) (Table 5).
Table 6
Correlation of Four Factors of Uncertainty and State Anxiety
R

P

Ambiguity

0.54

0.002

Complexity

-0.26

0.162

Inconsistency

0.39

0.034

Unpredictability

0.07

0.716
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Table 7
Correlation of Four Factors of Uncertainty and Trait Anxiety
R

P

Ambiguity

0.562

0.001

Complexity

-0.298

0.109

Inconsistency

0.642

0.000

Unpredictability

-0.064

0.735

Discussion
Sample. Participants were recruited from the Clinical Research Unit at an
NCI designated cancer center. Data was collected during the month of April
2009. The lack of heterogeneity was a limitation of the sample. The majority of
the sample accrued to the study had stage IV cancer and was receiving
experimental therapy in the clinical research unit, in an outpatient basis. The
median age was 66, and the majority of the patients completed high school. The
sample was predominantly male, and almost half of the sample was diagnosed
with melanoma. Over 13% of the sample had been diagnosed within 5 months of
enrollment and more than 16% were aware of their diagnosis for 5 years or
longer.
The results of this study cannot be generalized to other cancer patients
receiving standard therapy for an early stage disease. The anxiety and
uncertainty levels of the sample being studied could largely differ from the levels
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of a cancer population with a better prognosis and receiving standard therapy
with curative intent. Also, the sample was significantly dominated by males, so
the representation of females was low.
State-Trait Anxiety. In a study conducted on healthy and normal working
adults (Spielberger, et al., 1983), the mean score for state anxiety was 35.7 and
standard deviation of 10.4. Based on Spielberger‟s results, the anxiety levels
found in the present study sample were slightly lower than in healthy adults.
Spielberger‟s STAI is a very well tested instruments ad has been used
previously in patients with cancer. It is difficult to speculate reasons why anxiety
levels in this study sample were lower than the one found by Spielberger in
healthy adults. It is possible that this study sample, being predominantly stage VI
cancer patients, had resigned themselves to their illness and accepted it as lifelimiting, therefore decreasing their anxiety levels. Conversely, being in the
Clinical Research Unit might have made them feel hopeful, and therefore, less
anxious. Further study is needed to evaluate unmeasured variable to include
unequal gender representation, spirituality and hope.
Uncertainty in illness. Uncertainty scores were calculated using the four
factors to include ambiguity, complexity, inconsistency and unpredictability. The
total mean score for uncertainty was obtained by adding the scores of all four
factors. The mean total score found in the study sample was 86.4 with a standard
deviation of 11.4. The total scale mean score in Mishel‟s composite cancer
population had a total mean score of 69.46 with a standard deviation of 15.9
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(Mishel, 1987). This higher uncertainty mean score in the present sample may be
due to the receiving of experimental treatment with little information regarding the
treatment outcomes. It is possible that patients who choose experimental
treatment are different from other patients in some unknown way. Perhaps, these
patients feel more hopeful that experimental therapy will help, but at the same
time more uncertain about it.
It is also important to remark that due to the amount of intricate and varied
information provided during experimental therapy, one would expect that the
complexity mean score of the study sample would be higher than the mean score
of a generalized cancer population undergoing standard of care treatment.
Nevertheless, Mishel‟s composite cancer population had complexity mean score
(25.33 with standard deviation of 5.3) comparable to the mean score found on
this study (27.17 with a standard deviation of 4.202).
The Relationship between Uncertainty in Illness and Anxiety
The findings of this study suggest that the levels of state and trait anxiety
are higher among cancer patients with higher levels of uncertainty. This means
that there is a positive relationship between uncertainty and state and trait
anxiety. It is important to note that, unexpectedly, trait anxiety shows a stronger
relationship to uncertainty than state anxiety. However, the study sample was
small and further research is needed.
The results of this study also found that two out of four subcategories
(factors) of uncertainty, ambiguity and inconsistency, were positively related to
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both, state and trait anxiety. Both subcategories, ambiguity and inconsistency,
demonstrated a stronger relationship with trait anxiety. Given that trait anxiety
was found to have a stronger relationship with general uncertainty, as well as
with specific factors of uncertainty (ambiguity and inconsistency), the results
could suggest that patients who tend to have higher anxiety at all times (trait)
may be less able to tolerate uncertainty. Nevertheless, it is state anxiety that will
most likely be amenable to interventions by nurse practitioners.
Among the cancer population multiple studies have looked at the concepts
of uncertainty and anxiety. Nevertheless, the relationship between the two
concepts has not been widely studied. The only relevant study in the literature
(Kaminsky, 1991) showed similar results.
Implications for nursing
The findings of this study have implications for nursing. Assessment of
both uncertainty and anxiety at baseline as well as during patients‟ cancer should
be incorporated in the clinical practice. Given that a positive relationship was
found between uncertainty and anxiety, assessing uncertainty can predict the
presence of higher or lower level of anxiety, and vice versa. The study supports
that uncertainty and anxiety are present in the oncology population, and may
cause additional emotional distress.
A significant part of the nurses‟ role is to be patient advocates and have a
holistic approach in caring for patients. Research should be conducted further in
the areas of uncertainty and anxiety in order to develop guidelines for effective
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management of uncertainty. Furthermore, studies can research the effect of
proper uncertainty management in anxiety and the incorporation of such
managements in nursing education.
Conclusion
Anxiety levels were found to be higher in patients with higher levels of
uncertainty. The data suggests that this relationship is stronger between
uncertainty and trait anxiety. Two of the four uncertainty factors, ambiguity and
inconsistency, were found to be positively related to anxiety. Significant
relationships between anxiety or uncertainty and age, gender, diagnosis, stage or
educational level were not found.
Recommendation for future research
The findings of this study suggest the need for development of studies to
develop evidence-based clinical guidelines to better manage uncertainty and
anxiety. It would also be useful to study the effects that decreasing ambiguity and
inconsistency would have on anxiety levels.
The study could potentially be replicated with a larger sample, to include
inpatients and an equal sample of males and females. It would also be useful to
compare two groups, one undergoing standard of care therapy versus a group on
experimental therapy. Experimental interventions to decrease ambiguity and
inconsistencies could be designed and implemented to see their impact in the
levels of anxiety. A study could also be conducted to include the practitioner‟s
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perception of the patients‟ level of uncertainty and anxiety versus the patients‟
actual levels.

32

References
Albaugh, J. & Hacke, E. D. (2008) Measurement of quality of life in men with
prostate cancer. Clinical Journal of Oncology Nursing, 12(1), 81-86.
American Cancer Society. (2008). Cancer Facts and Figures. Retrieved July 4,
2008, from http://www.cancer.org
Bailey, D., Wallace M., & Mishel, M. (2007). Watching, waiting, and uncertainty in
prostate cancer. Journal of Clinical Nursing, 16(4), 734-741.
Barron, C. R. (2000). Stress, uncertainty, and health. In Hill-Rice, V. (Ed.).
Handbook of stress, coping, and health: Implications for nursing research,
theory and practice (pp. 517-535). London: Sage publishers.
Bay, E. J., & Algase, D. L. (1999). Fear and anxiety: A simultaneous concept
analysis. Nursing Diagnosis, 10(3), 103-111.
Carey, M. S., Bacon, M., Tu, D., Butler, L., Bezjak, A., &Stuart, G. C. The
prognostic effects of performance status and quality of life scores on
progression-free survival and overall survival in advanced ovarian cancer.
Gynecologic Oncology, 108(1), 100-105.
Clayton, M. F., Mishel, M., & Belyea, M. (2006). Testing a model of symptoms,
communication, uncertainty, and well-being, in older breast cancer
survivors. Research in Nursing & Health, 29, 18 uncertainty management
intervention for african american and white older breast cancer survivors:
20-Months outcomes. International Journal of Behavioral Medicine, 13(4),
286-294.
Decker, C. L., Hasse, J. E., & Bell, C. J. (2007). Uncertainty in adolescents
and young adults with cancer. Oncology Nursing Forum, 34 (3), 681-688.
Gatellari, M., Butow, P., & Tattersall, M. (2001). Sharing decisions in cancer care.
Social Science Medicine, 52(12), 1865-1878.
Germino, B. B., Mishel, M. H., Belyea, M., Harris, L., Ware, A., & Mohler, J.
(1998). Uncertainty in prostate cancer. Cancer Practice. 6(2), 107-113.
33

Gil, K., Mishel, M., Belyea, M., Germinio, B., Porter, L. S., & Clayton, M. (2006).
Benefits of childhood cancer. Journal of Nursing Research, 14(2), 133141.
Goodman, A. & Houck, K. (2001). Anxiety and uncertainty in informed decision
making. Journal of Women’s Health & Gender-based Medicine, 10(2), 9394.
Lee, Y. L. (2006). The relationship between uncertainty and posttraumatic stress
in survivors of -39.
Leventhal, H., Schmitz, M., Rabin, C., & Ward, S. (2009). Explaining
retrospective reports of symptoms in patients undergoing chemotherapy:
anxiety, initial symptom experience, and posttreatment symptoms. Annals
of Oncology, 20, 928-934.
McCormick, K. M. (2002). A concept analysis of uncertainty in illness. Journal of
Nursing Scholarship, 32 (2), 27-131.
Mishel, M. H. (1984). Perceived uncertainty and stress in illness. Research in
Nursing and Health, 7, 163-171.
Mishel, M. H. (1981). The measurement of uncertainty in illness. Nursing
Research, 30, 258- 263.
Mishel, M. H. (1988). Uncertainty in illness. Image: Journal of Nursing
Scholarship, 20(4), 225
Mishel, M. H. (1990). Re-conceptualization of the uncertainty in illness theory.
Image: Journal of Nursing Scholarship. 22(4), 256-262.
Osoba, David. (2004). The concept of quality of life in oncology. Oncology
Archive, 12(13); 166-167.
Owens, B. (2007). A test of the self-help model and use of complementary and
alternative medicine among hispanic women during treatment for breast
cancer. Oncology Nursing Forum, 34(4), E42-E50.
Pitcealthy, C., Maguire, P., Fletcher, I., Parle, M.,Tomenson, B. & Creed, F.
(2009). Can a brief psycholohical intervention prevent anxiety or
depressive disorder in cancer patients? A randomized controlled trial.
Annual Oncology 20(5), 928-934.
34

Polit, D.F. & Beck, C.T. (2008). Nursing Research; generating and assessing
evidencefor nursing practice (8th ed.) Philadelphina: Lippincott &
Wilkins.Santacroce, S. (2002). Uncertainty, anxiety, and symptoms of
posttraumatic stress in parents of children recently diagnosed with cancer.
Journal of Pediatric Oncology Nursing, 19, 104-111.
Powe B & Finne R., (2003). Cancer fatalism: the state of the science.
Cancer Nursing 26, 454-465.
Santacroce, S. (2002). Uncertainty, anxiety, and symptoms of posttraumatic
stress in parents of children recently diagnosed with cancer. Journal of
Pediatric Oncology Nursing, 19(3), 104-111.
Shaha, M., Cox, C. L., Talman, K., & Kelly, D. (2008). Uncertainty in breast,
prostate and colorectal cancer: Implication for supportive Care. Journal of
Nursing Scholarship, 40(1), 60-67.
Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., and Selby, P. (2002).
Anxiety disorders in cancer patients: their nature, associations and relation
to quality of life. Journal of Clinical Oncology., 20, 3137-3148.
Spielberger, C. D. (1983). STAI: Manual for the Stait-Trait Anxiety Inventory. Palo
Alto: Consulting Psychologists Press.
Tavoli, A., Mohagheghi, M. A., Montazer, A., Roshan, Rasool, Tavoli, Z., &
Omidvari, S. (2007). Anxiety and depression in patients with
gastrointestinal cancer: Does knowledge of cancer diagnosis matter?.
BMC Gastroenterology, 7(28), 101-106.
Wallace, M. (2005). Finding more meaning: The antecedents of uncertainty
revisited. Journal of Clinical Nursing, 14, 863-868.
Wallace, M., & Mishel, M. (2007). Watching, waiting, and uncertainty in prostate
cancer. Journal of Clinical Nursing, 16, 734-741.
Whitaker, Katriina, Brewin, C.R., & Watson, M. (2007). Intrusive cognitions and
anxiety in cancer patients. Journal of Psychosomatic Research, 64, 509517.
Zebrack B. (2000) Cancer survivor identity and quality of life. Cancer
Practice, 8, 238-242.

35

Appendices

36

Appendix A: Mishel Uncertainty in Illness Scale (MUIS)
MISHEL UNCERTAINTY IN ILLNESS SCALE – ADULT FORM
INSTRUCTIONS:
Please read each statement. Take your time and think about what each statement
says. Then place a “X” under the column that most closely measures how you
are feeling TODAY. If you agree with a statement, then you would mark under
either “Strongly Agree” or “Agree”. If you disagree with a statement, then mark
under either “Strongly Disagree” or “Disagree”. If you are undecided about how you feel, then mark
under “Undecided” for that statement. Please respond to every
statement.
1.

2.

I don’t know what is wrong with me.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______

I have a lot of questions without answers.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______

3. I am unsure if my illness is getting better or worse.

4.

Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

It is unclear how bad my pain will be.
Strongly Agree
(5)
_______

5.

Agree
(4)
______

The explanations they give about my condition seem hazy to me.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued)
6. The purpose of each treatment is clear to me.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

7. When I have pain, I know what this means about my condition.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

8. I do not know when to expect things will be done to me.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

_______

______

______

______

Strongly Disagree
(1)
______

9. My symptoms continue to change unpredictably.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

______

______

______

Strongly Disagree
(1)
______

10. I understand everything explained to me.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

11. The doctors say things to me that could have many meanings.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

12. I can predict how long my illness will last.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued)
13. My treatment is too complex to figure out.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

14. It is difficult to know if the treatments or medications I am getting are helping.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

15. There are so many different types of staff; it’s unclear who is responsible for what.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

16. Because of the unpredictability of my illness, I cannot plan for the future.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

17. The course of my illness keeps changing. I have good and bad days.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

18. It’s vague to me how I will manage my care after I leave the hospital.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

19. I have been given many differing opinions about what is wrong with me.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued)
20. It is not clear what is going to happen to me.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

21. I usually know if I am going to have a good or bad day.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

22. The results of my tests are inconsistent.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

23. The effectiveness of the treatment is undetermined.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

24. It is difficult to determine how long it will be before I can care for myself.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

25. I can generally predict the course of my illness.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

26. Because if the treatment, what I can do and cannot do keeps changing.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued)
27. I’m certain they will not find anything else wrong with me.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

28. The treatment I am receiving has a known probability of success.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

29. They have not given me a specific diagnosis.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

30. My physical distress is predictable; I know when it is going to get better or worse.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

31. I can depend on the nurses to be there when I need them.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

32. The seriousness of my illness has been determined.
Strongly Agree
(5)
_______

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

______

______

______

______

33. The doctors and nurses use everyday language so I can understand what they are saying.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)
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Disagree
(2)

Strongly Disagree
(1)

Appendix B: State Anxiety Inventory
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Appendix C: Trait Anxiety Inventory
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Appendix E: Letter of Approval from USF Institutional Review Board (Continued)
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Appendix F: Informed Consent Form
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Appendix F: Informed Consent Form (Continued)
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Appendix F: Informed Consent Form (Continued)
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Appendix F: Informed Consent Form (Continued)
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Appendix F: Informed Consent Form (Continued)
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